A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Clinical trial NCT01409135 · COMPLETED
Trial details
- NCT number
- NCT01409135
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-11
- Primary completion
- 2015-04-27
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.